Literature DB >> 8569420

Streptozotocin-induced diabetes increases fructose 2,6-biphosphate levels and glucose metabolism in thymus lymphocytes.

V R Moreno-Aurioles1, R Montaño, M Conde, R Bustos, F Sobrino.   

Abstract

Acute effect of streptozotocin-induced diabetes on several parameters of glucose metabolism was investigated in thymus lymphocytes (thymocytes). The cells from diabetics rats accumulated in vitro about 2-fold more fructose 2,6-bisphosphate (Fru-2, 6-P2) in the presence of increasing glucose concentration than cells from normal rats. An increased production of lactate was also observed. Phosphofructokinase-1 (PFK-1) and phosphofructokinase-2 (PFK-2) activities were enhanced in cells from diabetic rats compared with those from normal rats. [U-14C]glucose incorporation into glycogen was also increased in cells from diabetic rats and the 14CO2 liberation was lesser than in cells from normal animals. From these data it may be concluded that the response of thymocytes to streptozotocin-induced diabetes is similar to that observed in other extrahepatic tissues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8569420     DOI: 10.1016/0024-3205(95)02312-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

1.  PI3K-Akt signaling controls PFKFB3 expression during human T-lymphocyte activation.

Authors:  Helga Simon-Molas; Claudia Arnedo-Pac; Pere Fontova; Anna Vidal-Alabró; Esther Castaño; Ana Rodríguez-García; Àurea Navarro-Sabaté; Núria Lloberas; Anna Manzano; Ramon Bartrons
Journal:  Mol Cell Biochem       Date:  2018-02-12       Impact factor: 3.396

2.  Comparison of lymphomononuclear cell energy metabolism between healthy, impaired glucose intolerance and type 2 diabetes mellitus patients.

Authors:  L Ozsari; N Karadurmus; M Sahin; G Uckaya; A U Ural; M Kutlu
Journal:  Endocrine       Date:  2009-11-17       Impact factor: 3.633

3.  The evaluation of intracellular energy metabolism in prediabetic patients and patients newly diagnosed with type 2 diabetes mellitus

Authors:  Erkan Dulkadiroğlu; Hüseyin Özden; HÜseyİn Demİrcİ
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 0.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.